Check out the latest features and columns!

Pharmaceutical Executive November 2022

November's Executive Profile features Christi Shaw, CEO of Kite

A Mission of the Heart

Senior leaders focused on the advancement of digital medicine and health meet to discuss the importance of these tools for life sciences stakeholders

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

Pharm Exec profiles its 2022 Emerging Pharma Leaders

Pharm Exec's 2022 Emerging Pharma Leaders

 The windfall from COVID-19 vaccines and treatments has shaken up Pharm Exec’s latest listing of the top global biopharma sales producers in record-breaking fashion

2022 Pharm Exec 50

Articles

Agility and better decisions depend on managing risk and gaining insights from data by prioritizing patient and end-user needs. Companies of all sizes, including GSK, Boehringer-Ingelheim, Sanofi, AstraZeneca, and AbbVie, share best practices.

Mastering Patient Centricity’s Moving Parts: Innovators Share Real-World Examples 

Better technology is redefining pharmacovigilance as it expands beyond its traditional compliance focus to become a key business differentiator.

Doing More With Less: How Automation is Reshaping Drug Safety

Roku's Chris Schneider discusses how pharmaceutical marketers are still missing a huge population: the cord cutters.

Q&A With Chris Schneider, Vertical Marketing Lead, Pharma Health & Wellness for Roku

Pfizer CEO Albert Bourla, Ph.D., is in trouble for "misleading" and "overly promotional" claims he made during a BBC interview late last year about their COVID-19 vaccine for younger kids, which was not approved at the time.

Pfizer's Bourla Rebuked by UK's Prescription Medicines Code of Practice Authority (PMCPA) for Misleading Comments on Kids' Vaccines 

With biopharma sales and marketing changing faster than ever, it’s become crucial for brands to stay relevant with each new product launch. Christopher Price shares his point of view through the lens of 20 years of experience in the space. 

Q&A with Christopher Price, Boehringer Ingelheim's Go-to-Market Content Lead 

Building on Morgan Health’s accountable care strategy, Dr. Pegus will help inform the team’s renewed focus on population-based health initiatives, including investing in and scaling promising new care delivery models designed to improve health outcomes, particularly among diverse populations.

Dr. Cheryl Pegus, former Walmart EVP of Health & Wellness, Joins Morgan Health 

80% of Rx Patients Currently See Providers with Access to POC Media.

POCMA and MedFuse Release Analysis of the Complete Reach of POC Marketing

 and can be reached at fpollaro@mjhlifesciences.com.

Podcasts

In episode 122, Marcella Milliet Sciorra, Chief Marketing Officer at DeepIntent, discusses Connected TV, or CTV, how it differs from over the top, and how CTV fits into the future of pharmaceutical marketing.

Tuning Into CTV - Real Time Data For Marketers

Incyte Biosciences United Kingdom and Ireland Appoints Peter Williams As General Manager

This is the intelligence company's fifth acquisition.

Featured Content

Pharmaceutical Executive November 2022

A Mission of the Heart

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

Pharm Exec's 2022 Emerging Pharma Leaders

2022 Pharm Exec 50